GENEVA, Switzerland — Several giant US and international groups focused on fighting HIV and AIDS on Tuesday unveiled a plan to swiftly provide affordable access to a possibly 'game-changing' HIV prevention drug in lower-income countries.
The Global Fund, a partnership set up to battle AIDS, tuberculosis and malaria, said it had joined forces with PEPFAR, the main US program aimed at reducing the spread of HIV/AIDS, to 'rapidly provide affordable and equitable access to twice-yearly injectable lenacapavir for HIV pre-exposure prophylaxis (PrEP).'